Keam, B., Im, S., Kim, H., Oh, D., Kim, J. H., Lee, S., . . . Bang, Y. (2007). Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: Paradoxical features of the triple negative breast cancer. BioMed Central.
シカゴスタイル引用形Keam, Bhumsuk, et al. Prognostic Impact of Clinicopathologic Parameters in Stage II/III Breast Cancer Treated With Neoadjuvant Docetaxel and Doxorubicin Chemotherapy: Paradoxical Features of the Triple Negative Breast Cancer. BioMed Central, 2007.
MLA引用形式Keam, Bhumsuk, et al. Prognostic Impact of Clinicopathologic Parameters in Stage II/III Breast Cancer Treated With Neoadjuvant Docetaxel and Doxorubicin Chemotherapy: Paradoxical Features of the Triple Negative Breast Cancer. BioMed Central, 2007.